U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07443384) titled 'Complications Associated With Radiofrequency Microneedling in Dermatology: a Delphi Consensus' on Feb. 24.
Brief Summary: Radiofrequency microneedling (RFMN) combines controlled delivery of radiofrequency energy into the dermis or subcutaneous tissue through arrays of insulated or non-insulated microneedles. This targeted thermal stimulation induces fibroblast (re-)activation leading to collagen remodeling and neocollagenesis, leading to clinical improvement in skin laxity and rhytides. Despite widespread clinical use, recent FDA announcements have highlighted concerns regarding potentially serious complications associated with RFMN...